Ulcerative Colitis Acute
8
2
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Transfer of Feces in Ulcerative Colitis 2
Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
Feasibility Pilot Sequential Multiple Assignment Randomized Trial (SMART) for Acute Severe Ulcerative Colitis
Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)
Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management
Efficacy of Cyclosporine Rescue Therapy in Acute Ulcerative Colitis.
Indicators Predicting Surgery in Acute Severe Ulcerative Colitis(ASUC)